Generated: May 24, 2017
|Title:||Method of treating attention deficit disorders with d-threo methylphenidate|
|Abstract:||Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof.|
|Inventor(s):||Zeitlin; Andrew L. (Millington, NJ), Dariani; Maghsoud M. (Fanwood, NJ), Stirling; David I. (Branchburg, NJ)|
|Assignee:||Celgene Corporation (Warren, NJ)|
1. A method of treating at least one of Attention Deficit Disorder and Attention Deficit Hyperactivity Disorder and providing enhanced therapeutic activity, reduced side
effects euphoric effect, or potential for drug abuse as compared to racemic threo methylphenidate, said method comprising administering to a human exhibiting symptoms of such disorder therapeutically effective amounts of D-threo methylphenidate or
pharmaceutically acceptable salt thereof, substantially free of L-threo methylphenidate, on a daily basis.
2. The method according to claim 1 wherein the amount administered is 5 mg to 50 mg per day.
3. The method according to claim 1 wherein the amount of d-threo-methylphenidate or a pharmaceutically acceptable salt thereof is greater than 99% by weight.
4. The method according to claim 1 wherein said D-threo methylphenidate is administered together with a pharmaceutically acceptable carrier.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.